论文部分内容阅读
目的探讨性行为指导的个体化治疗在非肿瘤性血精症治疗中的作用。方法自2005年2月—2008年4月,89名非肿瘤性血精症患者随机分为常规治疗组(32例)和个体化治疗组(57例)。常规治疗组予以抗生素、安络血、维生素C口服。个体化治疗组根据精液、前列腺液常规分析及前列腺液或精液细菌培养,分为感染性和非感染性血精症,通过对患者的性行为指导,予以性行为指导的个体化治疗,并随访观察治疗效果。结果个体化治疗组治愈率和复发率为95.7%和3.5%,常规治疗组的治愈率和复发率为60.9%和9.4%。经x2检验,治疗结果有显著性差异,个体化治疗组优于常规治疗组(P<0.05)。结论性行为指导的个体化治疗非肿瘤性血精症疗效显著,具有较好的临床价值。
Objective To explore the role of individualized guidance of sexual behavior in the treatment of non-neoplastic sperm disease. Methods From February 2005 to April 2008, 89 patients with non-neoplastic sperm were randomly divided into routine treatment group (n = 32) and individualized treatment group (n = 57). Routine treatment group to antibiotics, blood and collaterals, vitamin C orally. Individualized treatment groups were divided into septic and non-infectious semen based on routine analysis of semen and prostatic fluid and bacterial culture of prostatic fluid or seminal fluid. Individualized treatment guided by sexual behavior was followed up and followed up Observe the effect of treatment. Results The cure rate and recurrence rate of the individualized treatment group were 95.7% and 3.5%, respectively. The cure rate and recurrence rate of the conventional treatment group were 60.9% and 9.4%. After x2 test, the treatment results were significantly different, individualized treatment group than the conventional treatment group (P <0.05). Conclusions Sexual orientation guided individualized treatment of non-neoplastic seminoma has significant curative effect and good clinical value.